Drug Induced Liver Injury (DILI): Impacts on Liver Functionality & Influence on NASH Drug Development

Time: 4:30 pm
day: Day Two


• Uncovering why DILI is a common liver issue in clinical trials
• Revealing the reasons why NASH patients have different level of alteration of liver enzymes
• Appreciating the fact that the assessment of DILI in NASH trials requires careful planning and evaluation